This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
SAN FRANCISCO — Investors attending the JP Morgan Healthcare Conference here this week appear to be most interested in the M&A strategies of the molecular biology tools firms presenting at the conference. And based on comments made by executives, it looks like 2007 will be another busy year for mergers and acquisitions.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.